Gavin Jancke

Directeur/Membre du Conseil chez Kv1.3 Therapeutics, Inc.

Health Technology

Relations actives

Nom	Sexe	Age	Sociétés liées	Collaboration
Craig Philips	M	64	Kv1.3 Therapeutics, Inc. Kv1.3 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kv1.3 Therapeutics, Inc. operates as a clinical stage biopharmaceutical firm. It focuses on providing new treatment options for rare autoimmune diseases. The company was founded in 2009 and is headquartered in Seattle, WA.	-
Shawn Iadonato	M	54	Kv1.3 Therapeutics, Inc. Kv1.3 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kv1.3 Therapeutics, Inc. operates as a clinical stage biopharmaceutical firm. It focuses on providing new treatment options for rare autoimmune diseases. The company was founded in 2009 and is headquartered in Seattle, WA.	-
Michael O. Banks	M	64	Kv1.3 Therapeutics, Inc. Kv1.3 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kv1.3 Therapeutics, Inc. operates as a clinical stage biopharmaceutical firm. It focuses on providing new treatment options for rare autoimmune diseases. The company was founded in 2009 and is headquartered in Seattle, WA.	-
Lucien Fouke	M	-	Kv1.3 Therapeutics, Inc. Kv1.3 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kv1.3 Therapeutics, Inc. operates as a clinical stage biopharmaceutical firm. It focuses on providing new treatment options for rare autoimmune diseases. The company was founded in 2009 and is headquartered in Seattle, WA.	-
Daniel Raymond	M	-	Kv1.3 Therapeutics, Inc. Kv1.3 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kv1.3 Therapeutics, Inc. operates as a clinical stage biopharmaceutical firm. It focuses on providing new treatment options for rare autoimmune diseases. The company was founded in 2009 and is headquartered in Seattle, WA.	-